Research paperBinding of mercury in renal brus-border and basolateral membrane-vesicles: Implication of a cysteine conjugate of mercury involved in the luminal uptake of inorganic mercury in the kidney☆
Abstract
The influence of the thiols l-cysteine (CYS), glutathione (GSH), and 2,3-dimercapto-1-propanesulfonate (DMPS) on the binding and transport of inorganic mercury (Hg2+) in luminal (brush-border) and basolateral membrane-vesicles isolated from the kidneys of rats was studied using radiolabeled mercury (203HgCl2). Membrane-vesicles were exposed to 1, 10, or 100 μM Hg2+ in the presence or absence of a 3:1 or 10:1 mole-ratio of CYS, GSH, or DMPS relative to Hg2+. Equilibration of mercury with the membrane-vesicles occurred very rapidly, essentially being complete within 5 sec. By 60 sec, binding accounted for 87–97% of intravesicular Hg2+ in the absence of exogenous thiols. All three thiols significantly reduced the fraction of binding, with DMPS being the most effective agent. CYS enhanced the association of Hg2+ with luminal membrane-vesicles relative to that when Hg2+ was added alone, suggesting that conjugation of Hg2+ with CYS promotes the transport of low concentrations of Hg2+. In contrast, an excess of either GSH or DMPS relative to Hg2+ interfered significantly with both the binding and transport of Hg2+ into either luminal or basolateral membrane-vesicles. In summary, the present study is the first to describe the association of Hg2+ with renal luminal and basolateral membrane-vesicles. Evidence was obtained for the involvement of a Hg2+-CYS conjugate as a mechanism by which Hg2+ uptake and binding to luminal membranes occur and for an inhibitory effect of GSH and the chelator DMPS with regard to Hg2+ uptake and binding, demonstrating that extracellular thiols can modulate significantly the renal accumulation of Hg2+.
References (40)
- RK Zalups
Organic anion transport and action of γ-glutamyltranspeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury
Toxicol Appl Pharmacol
(1995) - RK Zalups et al.
Pretreatment with p-aminohippurate inhibits the renal uptake and accumulation of injected inorganic mercury in the rat
Toxicology
(1995) - RK Zalups et al.
Accumulation of inorganic mercury along the renal proximal tubule of the rabbit
Toxicol Appl Pharmacol
(1990) - RK Zalups
Method for studying the in vivo accumulation of inorganic mercury in segments of the nephron in the kidneys of rats treated with mercuric chloride
J Pharmacol Methods
(1991) - RK Zalups
Autometallographic localization of inorganic mercury in the kidneys of rats: Effect of unilateral nephrectomy and compensatory renal growth
Exp Mol Pathol
(1991) - WO Berndt et al.
Renal glutathione and mercury uptake by kidney
Fundam Appl Toxicol
(1985) - T Tanaka et al.
Role of γ-glutamyltranspeptidase in renal uptake and toxicity of inorganic mercury in mice
Toxicology
(1990) - RK Zalups et al.
Nephrotoxicity of inorganic mercury co-administered with l-cysteine
Toxicology
(1996) - RK Zalups et al.
In vitro analysis of the accumulation and toxicity of inorganic mercury in segments of the proximal tubule isolated from the rabbit kidney
Toxicol Appl Pharmacol
(1993) - MD Aleo et al.
Primary cultures of rabbit renal proximal tubule cells. III. Comparative cytotoxicity of inorganic and organic mercury
Toxicol Appl Pharmacol
(1992)
Preparation of renal cortex basallateral and brush border membranes: Localization of adenylate cyclase and guanylate cyclase activities
Biochim Biophys Acta
γ-Glutamyl-p-nitroanilide: A new convenient substrate for determination and study of land d-γ-glutamyltranspeptidase activities
Biochim Biophys Acta
Possible role of hepatic glutathione in transport of methylmercury into mouse kidney
Biochem Pharmacol
Advances in understanding the renal transport and toxicity of mercury
J Toxicol Environ Health
Enhanced renal outer medullary uptake of mercury with uninephrectomy: Implication of a luminal mechanism
J Toxicol Environ Health
Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury
J Toxicol Environ Health
Tubular secretion and reabsorption of mercury compounds in mouse kidney
J Pharmocol Exp Ther
Role of extracellular glutathione and γ-glutamyltranspeptidase in the disposition and kidney toxicity of inorganic mercury in rats
J Appl Toxicol
Accumulation and handling of inorganic mercury in the kidney after co-administration with glutathione
J Toxicol Environ Health
Renal disposition of mercury in rats after intravenous injection of inorganic mercury and cysteine
J Toxicol Environ Health
Cited by (45)
Mercury
2021, Handbook on the Toxicology of Metals: Fifth EditionMercury occurs as elemental mercury and as inorganic and organic compounds (mercury vapor, mercury liquid, mercury salts, short-chain alkylmercury compounds, alkoxyalkylmercury compounds, and phenylmercury compounds), all with different toxicological properties. Total mercury can be analyzed in water, air, and biological material by cold vapor atomic absorption methods and by neutron activation analysis and can be detected down to concentrations of a 10th of a nanogram per gram in biological material. Methylmercury (MeHg) can be detected in biological material at levels of a few nanograms by extraction with benzene after strong acidification with hydrochloric acid, followed by gas chromatographic analysis of MeHg chloride. Other analytical methods for speciating inorganic mercury and several of the organomercurial forms have also been published. These methods include isotope dilution mass spectrometry, time-of-flight mass spectrometry, high-performance liquid chromatography inductively coupled plasma (ICP) mass spectrometry, capillary electrophoresis-ICP, gas chromatography-ICP, and X-ray absorption fine structure spectroscopy.
Mercury is circulated naturally in the biosphere, with 5500 metric tons (t) being released into the atmosphere by degassing from the Earth's crust and the oceans. In addition, 2500 t of mercury are released into the environment each year through human activities such as the combustion of fossil fuels and other industrial releases. Approximately 2000 tons of mercury per year is produced for industrial use, a small part of which is used for synthesizing organic mercury compounds. The world production of mercury for commercial uses has been slowly declining over the past 20 years. There is now a ban on the export of mercury from the European Union and the United States.
In nature, MeHg is produced from inorganic mercury as a consequence of microbial activity. In mammals, oxidative demethylation occurs in vivo to produce inorganic mercury. In fish, most mercury is present as MeHg. Factors determining the MeHg concentration in fish are the mercury content in water and bottom sediments, the pH and redox potential of water, and the species, age, and size of the fish.
The toxic properties of mercury vapor are a consequence of mercury accumulation in the brain causing neurological signs involving an unspecific psychasthenic and vegetative syndrome (micromercurialism). At high exposure levels, mercurial tremor is seen, accompanied by severe behavioral and personality changes, increased excitability, loss of memory, and insomnia. Mercurials may also affect other organ systems, such as the kidney. On a group basis, exposure levels are likely to be reflected by mercury concentrations in the blood and urine. Occupational exposure to mercury concentrations in air of >0.1 mg/m3 may produce mercurialism. Micromercurialism has not been reported at concentrations <0.01 mg/m3. Exposure to mercury vapor inhibits brain development in primates and in humans with certain genotypes. The exact dose–response relationship in humans is not known. Inorganic mercury, but not MeHg, has been found to induce and bind to the low molecular weight metal-binding protein, metallothionein.
The acute and long-term actions of mercuric salts, phenylmercury compounds, and alkoxyalkylmercury compounds are likely to be gastrointestinal disturbance and renal damage appearing as tubular dysfunction, with tubular necrosis in severe cases. The lethal dose in humans is approximately 1 g mercuric salt. The mercury load on the kidney is best determined by analysis of renal biopsy. Mercury concentrations in the kidney of between 10 and 70 mg/kg have been reported in poison cases with renal injury. Levels <3 mg/kg may be found in normal cases. Occasionally, mercuric compounds may cause idiosyncratic skin symptoms, which may develop into severe exfoliative dermatitis or cause glomerular nephritis. Animal and clinical observations have shown that mercuric mercury stimulates and MeHg inhibits the immune system. A specific form of idiosyncrasy, called acrodynia or pink disease, is seen in children. Most cases are associated with mercury exposure in which increased levels of mercury in urine are detected.
Hazards involved in the long-term intake of food containing MeHg or ethylmercury (EthylHg) and in occupational exposure to MeHg are a result of the efficient absorption (90%) of alkylmercury in humans and the long retention time (half-life of 70 days for MeHg and shorter for EthylHg) leading to accumulation of alkylmercury in the brain. Chronic poisoning results in degeneration and atrophy of the sensory cerebral cortex, paresthesia, ataxia, hearing, and visual impairment, and an increased risk for cardiovascular diseases such as myocardial infarction and stroke. The latter effects are attenuated by the intake of polyunsaturated fatty acids (PUFAs) through fish consumption. Prenatal exposure causes cerebral palsy and, in less severe cases, psychomotor retardation. MeHg concentration in the blood and hair reflects the body burden and the brain concentration of MeHg. Intake resulting in body burdens of <0.5 mg/kg body weight is not likely to give rise to detectable neurological signs in adults. This intake corresponds to blood values of <200 μg/L and mercury levels in the hair of <50 mg/kg. However, this level of MeHg exposure in pregnant women may result in inhibited brain development of the fetus, with psychomotor retardation of the child. This effect also appears to be reduced by the intake of PUFAs through fish consumption. The highest level of MeHg load in pregnant women that is not associated with inhibition of fetal brain development is not known. Recent epidemiological studies have revealed that genetic polymorphisms can modify mercury metabolism and susceptibility to mercury exposure. Specific genotypes have been associated with increased susceptibility to mercury exposure in humans.
Mechanisms Involved in the Renal Handling and Toxicity of Mercury
2018, Comprehensive Toxicology: Third EditionOne of the most important factors that determines the dispositional and toxicological fate of environmentally relevant forms of mercury in the body is the strong bonding affinity that exists between mercuric ions and reduced sulfur atoms of certain biomolecules. The formation of unique chemical species by the bonding of inorganic and organic mercuric ions in both extracellular and intracellular compartments of the body turns out to be a crucial part of the mechanisms involved in the handling and toxicity of inorganic and organic mercury in specific target tissues and organs, especially in the liver and kidneys. For example, certain membrane transporters present in renal proximal tubular epithelial cells have been shown to import certain species of mercury formed in extracellularly, while other transporters have been shown to export mercuric species formed in intracellular compartments of these target cells. Interestingly, the specific thiol S-conjugates that gain entry into the intracellular milieu of a target (renal) epithelial cell may not be the same type of thiol S-conjugate that is exported out of the cell. Over the last couple of decades, significant progress has been made in identifying membrane transporters in renal proximal tubular cells that take up and export certain thiol S-conjugates mercury. This chapter not only reviews the advances in understanding the roles of the transporters taking up and exporting endogenously formed species of mercury by renal tubular epithelial cells, but it also reviews some of the more relevant findings pertaining to key intracellular biochemical effects of mercuric ions that likely play a role in intoxicating proximal tubular cells. Moreover, discussion of factors that modify the proximal tubular uptake and subsequent toxicity of mercuric species has also been included.
Mercury
2015, Handbook on the Toxicology of Metals: Fourth EditionMercury occurs as elemental mercury and as inorganic and organic compounds (mercury vapor, mercury liquid, mercury salts, short-chain alkylmercury compounds, alkoxyalkylmercury compounds, and phenylmercury compounds), all with different toxicological properties. Total mercury can be analyzed in water, air, and biological material by cold vapor atomic absorption methods and by neutron activation analysis, and can be detected down to concentrations of a tenth of a nanogram per gram in biological material. Methylmercury (MeHg) can be detected in biological material at levels of a few nanograms by extraction with benzene after strong acidification with hydrochloric acid, followed by gas chromatographic analysis of MeHg chloride. Other analytical methods for speciating inorganic mercury and several of the organomercurial forms have also been published. These methods include isotope dilution mass spectrometry, time-of-flight mass spectrometry, high performance liquid chromatography inductively coupled (ICP) plasma mass spectrometry, capillary electrophoresis-ICP, gas chromatography-ICP, and X-ray absorption fine structure spectroscopy.
Mercury is circulated naturally in the biosphere, with 30,000-50,000 tons being released into the atmosphere by degassing from the Earth’s crust and the oceans. In addition, 20,000 tons of mercury is released into the environment each year through human activities such as combustion of fossil fuels and other industrial releases. Approximately 2000 tons of mercury per year is produced for industrial use, a small part of which is used for synthesizing organic mercury compounds. The world production of mercury for commercial uses has been slowly declining over the past 20 years. There is now a ban on the export of mercury from the European Union.
In nature, MeHg is produced from inorganic mercury as a consequence of microbial activity. In mammals, oxidative demethylation occurs in vivo to produce inorganic mercury. In fish, most mercury is present as MeHg. Factors determining the MeHg concentration in fish are the mercury content in water and bottom sediments, the pH and redox potential of water, and the species, age, and size of the fish.
The toxic properties of mercury vapor are a consequence of mercury accumulation in the brain causing neurological signs involving an unspecific psychoasthenic and vegetative syndrome (micromercurialism). At high exposure levels, mercurial tremor is seen, accompanied by severe behavioral and personality changes, increased excitability, loss of memory, and insomnia. Mercurials may also affect other organ systems, such as the kidney. On a group basis, exposure levels are likely to be reflected in mercury concentrations in the blood and urine. Occupational exposure to mercury concentrations in air of > 0.1 mg/m3 may produce mercurialism. Micromercurialism has not been reported at concentrations < 0.01 mg/m3. Exposure to mercury vapor inhibits brain development in primates and in humans with certain genotypes. The exact dose-response relationship in humans is not known. Inorganic mercury but not MeHg has been found to induce and bind to the low molecular weight metal-binding protein, metallothionein.
The acute and long-term actions of mercuric salts, phenylmercury compounds, and alkoxyalkylmercury compounds are likely to be gastrointestinal disturbance and renal damage appearing as tubular dysfunction, with tubular necrosis in severe cases. The lethal dose in humans is approximately 1 g mercuric salt. The mercury load on the kidney is best determined by analysis of renal biopsy. Mercury concentrations in the kidney of between 10 and 70 mg/kg have been reported in poison cases with renal injury. Levels < 3 mg/kg may be found in normal cases. Occasionally, mercuric compounds may cause idiosyncratic skin symptoms, which may develop into severe exfoliative dermatitis or cause glomerular nephritis. Animal and clinical observations have shown that mercuric mercury stimulates and MeHg inhibits the immune system. A specific form of idiosyncrasy, called acrodynia or pink disease, is seen in children. Most cases are associated with mercury exposure in which increased levels of mercury in urine are observed.
Hazards involved in the long-term intake of food containing MeHg or ethylmercury (EthylHg) and in occupational exposure to MeHg are a result of the efficient absorption (90%) of alkylmercury in humans and the long retention time (half-life of 70 days for MeHg and shorter for EthylHg) leading to accumulation of alkylmercury in the brain. Chronic poisoning results in degeneration and atrophy of the sensory cerebral cortex, paresthesia, ataxia, hearing, and visual impairment, and implies an increased risk for cardiovascular disease such as cardiac infarction and stroke. The latter effects are attenuated by the intake of polyunsaturated fatty acids (PUFAs) through fish consumption. Prenatal exposure causes cerebral palsy and, in less severe cases, psychomotor retardation. MeHg concentration in the blood and hair reflects the body burden and the brain concentration of MeHg. Intake resulting in body burdens of < 0.5 mg/kg body weight is not likely to give rise to detectable neurological signs in adults. This intake corresponds to blood values of < 200 μg/L and mercury levels in the hair of < 50 mg/kg. However, this level of MeHg exposure in pregnant women may result in inhibited brain development of the fetus, with psychomotor retardation of the child. This effect also appears to be reduced by intake of PUFAs through fish consumption. The highest level of MeHg load in pregnant women that is not associated with inhibition of fetal brain development is not known. Recent epidemiological studies have revealed that genetic polymorphisms can modify mercury metabolism and susceptibility to mercury exposure. Specific genotypes have been associated with increased susceptibility to mercury exposure in humans.
A general overview of mercury from a historical perspective has been reviewed by Goldwater (1972). The pharmacology and toxicology of mercury was previously reviewed by Clarkson et al. (1972), the chemistry of mercury in biological systems by Carty and Malone (1979), the toxicology of MeHg by a Swedish Expert Group (1971), and the toxicology and epidemiology of mercury by Friberg and Vostal (1972), the Task Group on Metal Accumulation (1973), the Task Group on Metal Toxicity (1976), and the World Health Organization (WHO (World Health Organization), 1976, WHO, 1980, WHO., 1990, WHO., 1991). The toxicology of mercury has been reviewed in the U.S. Environmental Protection Agency Report to Congress (EPA, 1997), the Agency for Toxic Substances and Disease Registry (ATSDR, 1999), National Academy of Sciences National Research Council (NAS/NRC, 2000), and Institute of Medicine Report on Mercury in Vaccines (IOM, 2004).
Mercury
2014, Handbook on the Toxicology of MetalsMercury occurs as elemental mercury and as inorganic and organic compounds (mercury vapor, mercury liquid, mercury salts, short-chain alkylmercury compounds, alkoxyalkylmercury compounds, and phenylmercury compounds), all with different toxicological properties. Total mercury can be analyzed in water, air, and biological material by cold vapor atomic absorption methods and by neutron activation analysis, and can be detected down to concentrations of a tenth of a nanogram per gram in biological material. Methylmercury (MeHg) can be detected in biological material at levels of a few nanograms by extraction with benzene after strong acidification with hydrochloric acid, followed by gas chromatographic analysis of MeHg chloride. Other analytical methods for speciating inorganic mercury and several of the organomercurial forms have also been published. These methods include isotope dilution mass spectrometry, time-of-flight mass spectrometry, high performance liquid chromatography inductively coupled (ICP) plasma mass spectrometry, capillary electrophoresis-ICP, gas chromatography-ICP, and X-ray absorption fine structure spectroscopy.
Mercury is circulated naturally in the biosphere, with 30,000-50,000 tons being released into the atmosphere by degassing from the Earth’s crust and the oceans. In addition, 20,000 tons of mercury is released into the environment each year through human activities such as combustion of fossil fuels and other industrial releases. Approximately 2000 tons of mercury per year is produced for industrial use, a small part of which is used for synthesizing organic mercury compounds. The world production of mercury for commercial uses has been slowly declining over the past 20 years. There is now a ban on the export of mercury from the European Union.
In nature, MeHg is produced from inorganic mercury as a consequence of microbial activity. In mammals, oxidative demethylation occurs in vivo to produce inorganic mercury. In fish, most mercury is present as MeHg. Factors determining the MeHg concentration in fish are the mercury content in water and bottom sediments, the pH and redox potential of water, and the species, age, and size of the fish.
The toxic properties of mercury vapor are a consequence of mercury accumulation in the brain causing neurological signs involving an unspecific psychoasthenic and vegetative syndrome (micromercurialism). At high exposure levels, mercurial tremor is seen, accompanied by severe behavioral and personality changes, increased excitability, loss of memory, and insomnia. Mercurials may also affect other organ systems, such as the kidney. On a group basis, exposure levels are likely to be reflected in mercury concentrations in the blood and urine. Occupational exposure to mercury concentrations in air of > 0.1 mg/m3 may produce mercurialism. Micromercurialism has not been reported at concentrations < 0.01 mg/m3. Exposure to mercury vapor inhibits brain development in primates and in humans with certain genotypes. The exact dose-response relationship in humans is not known. Inorganic mercury but not MeHg has been found to induce and bind to the low molecular weight metal-binding protein, metallothionein.
The acute and long-term actions of mercuric salts, phenylmercury compounds, and alkoxyalkylmercury compounds are likely to be gastrointestinal disturbance and renal damage appearing as tubular dysfunction, with tubular necrosis in severe cases. The lethal dose in humans is approximately 1 g mercuric salt. The mercury load on the kidney is best determined by analysis of renal biopsy. Mercury concentrations in the kidney of between 10 and 70 mg/kg have been reported in poison cases with renal injury. Levels < 3 mg/kg may be found in normal cases. Occasionally, mercuric compounds may cause idiosyncratic skin symptoms, which may develop into severe exfoliative dermatitis or cause glomerular nephritis. Animal and clinical observations have shown that mercuric mercury stimulates and MeHg inhibits the immune system. A specific form of idiosyncrasy, called acrodynia or pink disease, is seen in children. Most cases are associated with mercury exposure in which increased levels of mercury in urine are observed.
Hazards involved in the long-term intake of food containing MeHg or ethylmercury (EthylHg) and in occupational exposure to MeHg are a result of the efficient absorption (90%) of alkylmercury in humans and the long retention time (half-life of 70 days for MeHg and shorter for EthylHg) leading to accumulation of alkylmercury in the brain. Chronic poisoning results in degeneration and atrophy of the sensory cerebral cortex, paresthesia, ataxia, hearing, and visual impairment, and implies an increased risk for cardiovascular disease such as cardiac infarction and stroke. The latter effects are attenuated by the intake of polyunsaturated fatty acids (PUFAs) through fish consumption. Prenatal exposure causes cerebral palsy and, in less severe cases, psychomotor retardation. MeHg concentration in the blood and hair reflects the body burden and the brain concentration of MeHg. Intake resulting in body burdens of < 0.5 mg/kg body weight is not likely to give rise to detectable neurological signs in adults. This intake corresponds to blood values of < 200 μg/L and mercury levels in the hair of < 50 mg/kg. However, this level of MeHg exposure in pregnant women may result in inhibited brain development of the fetus, with psychomotor retardation of the child. This effect also appears to be reduced by intake of PUFAs through fish consumption. The highest level of MeHg load in pregnant women that is not associated with inhibition of fetal brain development is not known. Recent epidemiological studies have revealed that genetic polymorphisms can modify mercury metabolism and susceptibility to mercury exposure. Specific genotypes have been associated with increased susceptibility to mercury exposure in humans.
A general overview of mercury from a historical perspective has been reviewed by Goldwater (1972). The pharmacology and toxicology of mercury was previously reviewed by Clarkson et al. (1972), the chemistry of mercury in biological systems by Carty and Malone (1979), the toxicology of MeHg by a Swedish Expert Group (1971), and the toxicology and epidemiology of mercury by Friberg and Vostal (1972), the Task Group on Metal Accumulation (1973), the Task Group on Metal Toxicity (1976), and the World Health Organization (WHO (World Health Organization), 1976, WHO, 1980, WHO., 1990, WHO., 1991). The toxicology of mercury has been reviewed in the U.S. Environmental Protection Agency Report to Congress (EPA, 1997), the Agency for Toxic Substances and Disease Registry (ATSDR, 1999), National Academy of Sciences National Research Council (NAS/NRC, 2000), and Institute of Medicine Report on Mercury in Vaccines (IOM, 2004).
Cytoprotective Systems within the Kidney
2010, Comprehensive Toxicology, Second EditionThe kidneys are particularly susceptible to injury from a diverse array of chemicals and drugs, including some that are therapeutic agents for which nephrotoxicity limits their efficacy. Additionally, several diseases and pathological states, such as diabetes and cardiovascular disease, exhibit renal dysfunction as a significant complication. Accordingly, identification of protective agents or development of strategies to prevent cell death or enhance cellular repair and/or proliferation is needed. This chapter will review cytoprotective mechanisms in renal proximal tubular cells, focusing on three classes of processes that have been the best studied: (1) thiol-disulfide redox protectants, including the glutathione and thioredoxin systems, metallothionein, N-acetyl-l-cysteine, and other low-molecular-weight thiols; (2) modulation of signaling pathways, involving epidermal growth factor, the mitogen-activated protein kinase family, protein kinase C and B (Akt), heat shock proteins, p53 and p21, peroxisome proliferator activator receptor-γ coactivator-1α (PGC-1α), BH3-family proteins, and the Nrf2 and NF-κB pathways; and (3) modulation of renal physiological function, focusing on intracellular pH and glycine and chloride channels. While this listing of cytoprotective mechanisms that can function in the kidneys is by no means complete, it demonstrates the diversity and breadth of protective systems that serve to balance the susceptibility of the kidneys, in particular the proximal tubular cells, and restore cellular and/or tissue function in disease states or after toxic insults.
Mercury
2007, Handbook on the Toxicology of Metals
- ☆
This research was supported by National Institute of Environmental Health Sciences Grant 5 R01-ES05157 and -ES05980. L.H.L. is the recipient of a Research Career Development Award from the National Institute of Diabetes and Digestive and Kidney Diseases (Grant K04-DK02090).